Statewide

New Hampshire Bureau of Emergency Medical Services

Current236 dose entries57 drugs4 documentsNHeffective 2025-11-0797% machine-parsed of 236

New Hampshire Bureau of Emergency Medical Services (NH) carries 57 drugs across 236 dose entries in its current published protocol, effective 2025-11-07.

Drugs and doses57

Acetaminophen

Indication	Population	Dose	Route	Repeat	Standing	Source
Fever	adult	500–1000 mg	PO	not captured	standing	pages 39, 40, 232
Fever	adult	500–1000 mg	PR	not captured	standing	pages 39, 40, 232
Fever	adult	500–1000 mg	IV	not captured	standing	pages 39, 40, 232
Fever	peds	15 mg/kg	IV	not captured	standing	pages 39, 40, 232
Mild to moderate pain	adult	1000 mg	IV	not captured	standing	pages 59, 62, 232
Mild to moderate pain	adult	325–1000 mg	PO	not captured	standing	pages 59, 232
Mild to moderate pain	peds	15 mg/kg	IV	not captured	standing	pages 59, 62, 232

Activated Charcoal

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	25–50 g	PO	not captured	standing	pages 64, 232

Adenosine

Indication	Population	Dose	Route	Repeat	Standing	Source
Narrow-complex tachycardia	adult	6 mg	IV	not captured	standing	pages 91, 93, 232
Narrow-complex tachycardia	peds	0.1 mg/kg (max 6 mg)	IV	not captured	standing	pages 91, 93, 232

Albuterol

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	2.5 mg	NEB	not captured	standing	pages 25, 27, 233
Anaphylaxis	peds	2.5 mg	NEB	not captured	standing	pages 25, 27, 233
Asthma / bronchospasm	adult	2.5 mg	NEB	not captured	standing	pages 28, 29, 233
Asthma / bronchospasm	adult	4–6 puff	MDI	not captured	standing	pages 28, 29, 233
Asthma / bronchospasm	peds	2.5 mg	NEB	not captured	standing	pages 28, 29, 233
Asthma / bronchospasm	peds	4–6 puff	MDI	not captured	standing	pages 28, 29, 233
Hyperkalemia	adult	10–20 mg	NEB	not captured	standing	pages 42, 43, 233
Hyperkalemia	peds	2.5–10 mg	NEB	not captured	standing	pages 42, 43, 233

Amiodarone

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	150 mg	IV/IO	not captured	standing	pages 92, 93, 233
Other	peds	5 mg/kg (max 300 mg)	IV/IO	not captured	standing	pages 92, 93, 233

Aspirin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	324 mg	PO	not captured	standing	pages 79, 80, 233

Atropine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	1 mg	IV	not captured	standing	pages 82, 83, 234
Bradycardia	peds	0.02 mg/kg	IV	not captured	standing	pages 82, 83, 234
Cardiac arrest	peds	0.04 mg/kg	IV	not captured	standing	pages 87, 169, 234
Organophosphate poisoning	adult	2 mg	IV/IM	not captured	standing	pages 50, 51, 234
Organophosphate poisoning	peds	0.05–0.1 mg/kg	IV/IM	not captured	standing	pages 50, 51, 234

Calcium Chloride

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperkalemia	adult	1 g	IV/IO	not captured	standing	pages 42, 43, 234
Hyperkalemia	peds	20 mg/kg (max 1 g)	IV/IO	not captured	standing	pages 42, 43, 234

Calcium Gluconate

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperkalemia	adult	3 g	IV/IO	not captured	standing	pages 42, 43, 235
Hyperkalemia	peds	100 mg/kg (max 3 g)	IV/IO	not captured	standing	pages 42, 43, 235

Ceftriaxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1 g	IV/IM	not captured	standing	page 104
Other	peds	50 mg/kg	IV/IM	not captured	standing	page 104

Dexamethasone

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	10 mg	IV/IM/PO	not captured	standing	pages 26, 27, 235
Anaphylaxis	peds	0.6 mg/kg	IV/IM/PO	not captured	standing	pages 26, 27, 235
Asthma / bronchospasm	adult	10 mg	IV/IM/PO	not captured	standing	pages 28, 235
Croup	peds	0.6 mg/kg	IV/IM/PO	not captured	standing	pages 29, 30

Dextrose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	10% solution	IV	not captured	standing	pages 45, 46
Hypoglycemia	peds	5 mL/kg	IV	not captured	standing	pages 45, 46

Diazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	5 mg	IV	not captured	standing	pages 32, 236
Bradycardia	adult	5 mg	IV	not captured	standing	pages 82, 83, 236
Bradycardia	peds	0.1 mg/kg	IV	not captured	standing	pages 82, 83, 236
Hyperthermia	adult	5 mg	IV	not captured	standing	pages 44, 236
Hyperthermia	peds	0.1 mg/kg	IV	not captured	standing	pages 44, 236
Nerve agent exposure	adult	10 mg	IM	not captured	standing	pages 50, 236
Nerve agent exposure	adult	5 mg	IV	not captured	standing	pages 50, 51, 236
Nerve agent exposure	peds	0.2 mg/kg	IV	not captured	standing	pages 50, 51, 236
Other	adult	10 mg	IV	not captured	standing	pages 34, 35, 143, 144, 236
Other	adult	5 mg	IV	not captured	standing	pages 118, 236
Other	adult	5 mg	IV	not captured	standing	pages 120, 236
Other	adult	5 mg	IV	not captured	standing	pages 64, 66, 236
Other	peds	0.1 mg/kg	IV	not captured	standing	pages 120, 236
Other	peds	0.1 mg/kg	IV	not captured	standing	pages 64, 66, 236
Other	peds	0.2 mg/kg	IV	not captured	standing	pages 34, 35, 143, 144, 236
Seizure	adult	10 mg	IV	not captured	standing	pages 68, 69, 236
Seizure	peds	0.2 mg/kg	IV	not captured	standing	pages 68, 69, 236
Narrow-complex tachycardia	adult	5 mg	IV	not captured	standing	pages 91, 93, 236
Narrow-complex tachycardia	peds	0.1 mg/kg	IV	not captured	standing	pages 91, 93, 236

Diltiazem

Indication	Population	Dose	Route	Repeat	Standing	Source
Narrow-complex tachycardia	adult	0.25 mg/kg	IV	not captured	standing	pages 91, 236

Diphenhydramine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	25–50 mg	IV/IM/PO	not captured	standing	pages 25, 26, 27, 237
Anaphylaxis	peds	1 mg/kg	IV/IM/PO	not captured	standing	pages 25, 26, 27, 237
Dystonic reaction	adult	25–50 mg	IV/IM	not captured	standing	pages 35, 49, 237
Other	adult	25–50 mg	IV/IM	not captured	standing	pages 64, 66, 237
Other	adult	25–50 mg	IV/IM	not captured	standing	pages 35, 237
Other	adult	25 mg	PO	not captured	standing	pages 49, 237
Other	peds	1 mg/kg	IV/IM	not captured	standing	pages 64, 66, 237
Other	peds	6.25–25 mg	PO	not captured	standing	pages 49, 237

Droperidol

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	1.25 mg	IV/IM	not captured	standing	pages 49, 237
Other	adult	5–10 mg	IV/IM	not captured	standing	pages 34, 143, 237

Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	0.3 mg	IM	not captured	standing	pages 25, 27, 163
Anaphylaxis	peds	0.15 mg	IM	not captured	standing	pages 25, 27, 163
Asthma / bronchospasm	adult	0.3 mg	IM	not captured	standing	pages 28, 29
Asthma / bronchospasm	peds	0.15 mg	IM	not captured	standing	pages 28, 29
Bradycardia	adult	2–10 mcg	IV/IO	not captured	standing	page 82
Cardiac arrest	adult	1 mg	IV/IO	not captured	standing	pages 52, 85, 86, 87, 169
Cardiac arrest	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 52, 85, 86, 87, 169
Other	peds	3 mg	NEB	not captured	standing	page 29
Other	peds	3 mg	NEB	not captured	standing	page 29
Sepsis	peds	0.05–1 mcg/kg	IV/IO	not captured	standing	pages 70, 71, 90

Etomidate

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI induction	adult	0.3 mg/kg	IV	not captured	standing	pages 186, 239

Famotidine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	20 mg	IV/IM/PO	not captured	standing	pages 26, 239

Fentanyl

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	25–100 mcg	IV	not captured	standing	pages 59, 62, 239, 248
Mild to moderate pain	adult	50–100 mcg	IM/IN	not captured	standing	pages 59, 62, 239, 248
Mild to moderate pain	peds	0.5–1 mcg/kg	IV	not captured	standing	pages 59, 62, 239, 248
Mild to moderate pain	peds	0.5–1 mcg/kg	IM/IN	not captured	standing	pages 59, 62, 239, 248
Post-intubation sedation	adult	0.5–1 mcg/kg	IV	not captured	standing	pages 117, 239
Post-intubation sedation	peds	1–2 mcg/kg	IV	not captured	standing	pages 117, 239
RSI induction	adult	0.5–1 mcg/kg	IV	not captured	standing	pages 187, 239
RSI induction	peds	0.5–1 mcg/kg	IV	not captured	standing	pages 187, 239

Glucagon

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	5 mg	IV	not captured	standing	pages 82, 83, 239
Beta-blocker / calcium-channel-blocker overdose	peds	0.5 mg	IV	not captured	standing	pages 82, 83, 239
Hypoglycemia	adult	1 mg	IM	not captured	standing	pages 45, 46, 239
Hypoglycemia	peds	0.5 mg	IM	not captured	standing	pages 45, 46, 239

Haloperidol

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	10 mg	IM	not captured	standing	pages 34, 143

Heparin

Indication	Population	Dose	Route	Repeat	Standing	Source
STEMI	adult	60 unit/kg	IV	not captured	standing	pages 79, 81, 240

Hydrocortisone

Indication	Population	Dose	Route	Repeat	Standing	Source
Adrenal crisis	adult	100 mg	IV/IM	not captured	standing	page 24
Adrenal crisis	adult	50 mg	IV	not captured	standing	page 24
Adrenal crisis	peds	2 mg/kg	IV/IM	not captured	standing	page 24
Adrenal crisis	peds	2 mg/kg	IV	not captured	standing	page 24

Hydromorphone

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	0.5–1 mg	IV	not captured	standing	pages 59, 62, 241, 248
Mild to moderate pain	adult	1–2 mg	IM	not captured	standing	pages 59, 248
Mild to moderate pain	peds	0.01–0.02 mg/kg	IV	not captured	standing	pages 59, 62, 241, 248

Hydroxocobalamin

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	5 g	IV	not captured	standing	page 73
Other	peds	70 mg/kg	IV	not captured	standing	page 73

Ibuprofen

Indication	Population	Dose	Route	Repeat	Standing	Source
Fever	adult	600 mg	PO	not captured	standing	pages 39, 40, 241
Fever	peds	10 mg/kg	PO	not captured	standing	pages 39, 40, 241
Other	adult	400–600 mg	PO	not captured	standing	pages 104, 241
Other	peds	10 mg/kg	PO	not captured	standing	pages 104, 241
Mild to moderate pain	adult	600 mg	PO	not captured	standing	pages 59, 61, 241
Mild to moderate pain	peds	10 mg/kg	PO	not captured	standing	pages 59, 61, 241

Ipratropium

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	0.5 mg	NEB	not captured	standing	pages 28, 29, 233, 241
Asthma / bronchospasm	peds	0.5 mg	NEB	not captured	standing	pages 28, 29, 233, 241

Ketamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	10–20 mg	IV	not captured	standing	pages 82, 83, 242
Bradycardia	adult	25–50 mg	IM	not captured	standing	pages 82, 242
Bradycardia	peds	0.1–0.25 mg/kg	IV	not captured	standing	pages 82, 83, 242
Other	adult	1 mg/kg	IV	not captured	standing	pages 34, 143
Other	adult	4 mg/kg	IM	not captured	standing	pages 34, 35, 143, 144
Mild to moderate pain	adult	10–20 mg	IV	not captured	standing	pages 59, 62, 242
Mild to moderate pain	adult	25–50 mg	IM/IN	not captured	standing	pages 59, 62, 242
Mild to moderate pain	peds	0.5–1 mg/kg	IM/IN	not captured	standing	pages 59, 62, 242
Post-intubation sedation	adult	1 mg/kg	IV	not captured	standing	pages 117, 242
Post-intubation sedation	peds	1 mg/kg	IV	not captured	standing	pages 117, 242
RSI induction	adult	2 mg/kg	IV	not captured	standing	pages 186, 242
RSI induction	adult	4 mg/kg	IM	not captured	standing	pages 186, 242
Narrow-complex tachycardia	adult	10–20 mg	IV	not captured	standing	pages 91, 242
Narrow-complex tachycardia	adult	25–50 mg	IM	not captured	standing	pages 91, 242

Ketorolac

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	15 mg	IV/IM	not captured	standing	pages 59, 243

Labetalol

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	20 mg	IV	not captured	standing	pages 54, 243

Lidocaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1–1.5 mg/kg	IV/IO	not captured	standing	pages 87, 92
Other	peds	1 mg/kg	IV/IO	not captured	standing	pages 87, 92
Narrow-complex tachycardia	adult	1–1.5 mg/kg	IV	not captured	standing	page 92

Lorazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	1 mg	IV	not captured	standing	pages 32, 244
Bradycardia	adult	1 mg	IV	not captured	standing	pages 82, 244
Hyperthermia	adult	1 mg	IV	not captured	standing	pages 44, 244
Hyperthermia	peds	0.05 mg/kg	IV	not captured	standing	pages 44, 244
Nerve agent exposure	adult	2–4 mg	IV	not captured	standing	pages 50, 51, 244
Nerve agent exposure	peds	0.1 mg/kg	IV	not captured	standing	pages 50, 51, 244
Other	adult	1 mg	IV	not captured	standing	pages 118, 244
Other	adult	1 mg	IV	not captured	standing	pages 120, 244
Other	adult	1 mg	IV	not captured	standing	pages 64, 66, 244
Other	adult	1 mg	IV	not captured	standing	pages 34, 143, 244
Other	adult	2–4 mg	IV	not captured	standing	pages 34, 143, 244
Post-intubation sedation	adult	1–2 mg	IV	not captured	standing	pages 117, 244
Post-intubation sedation	peds	0.05 mg/kg	IV	not captured	standing	pages 117, 244
Seizure	adult	2–4 mg	IV	not captured	standing	pages 68, 69, 244
Seizure	peds	0.1 mg/kg	IV	not captured	standing	pages 68, 69, 244
Narrow-complex tachycardia	adult	1 mg	IV	not captured	standing	pages 91, 244

Magnesium Sulfate

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	2 g	IV	not captured	standing	pages 28, 245
Other	adult	1–2 g	IV	not captured	standing	pages 92, 245
Other	adult	4 g	IV	not captured	standing	pages 55, 245
Other	peds	25–50 mg/kg	IV	not captured	standing	pages 92, 245
Seizure	adult	4 g	IV	not captured	standing	pages 55, 68, 245

Methylprednisolone

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	125 mg	IV/IM	not captured	standing	pages 26, 27, 245
Anaphylaxis	peds	1–2 mg/kg	IV/IM	not captured	standing	pages 26, 27, 245
Asthma / bronchospasm	adult	125 mg	IV/IM	not captured	standing	pages 28, 29, 245
Asthma / bronchospasm	peds	2 mg/kg	IV/IM	not captured	standing	pages 28, 29, 245

Metoclopramide

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	5 mg	IV	not captured	standing	pages 49, 245

Metoprolol

Indication	Population	Dose	Route	Repeat	Standing	Source
Narrow-complex tachycardia	adult	5 mg	IV	not captured	standing	pages 91, 246

Midazolam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	2.5 mg	IV	not captured	standing	page 32
Agitation	adult	5 mg	IM/IN	not captured	standing	page 32
Hyperthermia	adult	2.5 mg	IV	not captured	standing	page 44
Hyperthermia	adult	5 mg	IM/IN	not captured	standing	page 44
Hyperthermia	peds	0.05 mg/kg	IV	not captured	standing	page 44
Hyperthermia	peds	0.1 mg/kg	IM/IN	not captured	standing	page 44
Nerve agent exposure	adult	10 mg	IM/IN	not captured	standing	pages 50, 51
Nerve agent exposure	adult	5 mg	IV	not captured	standing	pages 50, 51
Nerve agent exposure	peds	0.1 mg/kg	IV	not captured	standing	pages 50, 51
Nerve agent exposure	peds	0.2 mg/kg	IM/IN	not captured	standing	pages 50, 51
Other	adult	2.5 mg	IV	not captured	standing	page 34
Other	adult	2.5 mg	IV	not captured	standing	pages 64, 66
Other	adult	2.5 mg	IV	not captured	standing	pages 118, 120
Other	adult	2.5 mg	IN	not captured	standing	page 203
Other	adult	5 mg	IM/IN	not captured	standing	page 34
Other	adult	5 mg	IV	not captured	standing	pages 34, 35
Other	adult	5 mg	IM/IN	not captured	standing	pages 64, 66
Other	adult	5 mg	IM/IN	not captured	standing	pages 118, 120
Other	peds	0.05 mg/kg	IV	not captured	standing	pages 64, 66
Other	peds	0.05 mg/kg	IV	not captured	standing	pages 118, 120
Other	peds	0.1 mg/kg	IV	not captured	standing	pages 34, 35
Other	peds	0.1 mg/kg	IM/IN	not captured	standing	pages 64, 66
Other	peds	0.1 mg/kg	IM/IN	not captured	standing	pages 118, 120
Other	peds	0.2 mg/kg	IM/IN	not captured	standing	pages 34, 35
Procedural sedation	adult	2–2.5 mg	IV/IO	not captured	standing	page 15
Seizure	adult	10 mg	IM/IN	not captured	standing	pages 68, 69
Seizure	adult	5 mg	IV	not captured	standing	pages 68, 69
Seizure	peds	0.1 mg/kg	IV	not captured	standing	pages 68, 69
Seizure	peds	0.2 mg/kg	IM/IN	not captured	standing	pages 68, 69
Narrow-complex tachycardia	adult	2.5 mg	IV	not captured	standing	pages 91, 93
Narrow-complex tachycardia	adult	5 mg	IM/IN	not captured	standing	pages 91, 93
Narrow-complex tachycardia	peds	0.05 mg/kg	IV	not captured	standing	pages 91, 93
Narrow-complex tachycardia	peds	0.1 mg/kg	IM/IN	not captured	standing	pages 91, 93

Morphine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	Dosing per Pain Protocol	IV/IM	not captured	standing	pages 203, 248
Mild to moderate pain	adult	2–10 mg	IV/IM	not captured	standing	pages 59, 62, 248
Mild to moderate pain	peds	0.1 mg/kg	IV/IM	not captured	standing	pages 59, 62, 248

Naloxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Opioid overdose	adult	0.4–2 mg	IV	not captured	standing	pages 57, 58
Opioid overdose	adult	0.4–2 mg	IM	not captured	standing	pages 57, 58
Opioid overdose	adult	1 mg	IN	not captured	standing	pages 57, 58
Opioid overdose	peds	0.1 mg/kg	IV	not captured	standing	pages 57, 58
Opioid overdose	peds	0.1 mg/kg	IM	not captured	standing	pages 57, 58
Opioid overdose	peds	0.5 mg	IN	not captured	standing	pages 57, 58

Nerve Agent Antidote Kit

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	3 auto-injectors	IM	not captured	standing	pages 50, 51, 234
Nerve agent exposure	peds	1 auto-injector	IM	not captured	standing	pages 50, 51, 234

Nifedipine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	10 mg	PO	not captured	standing	pages 3, 54, 248

Nitroglycerin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	0.4 mg	SL	not captured	standing	page 79
CHF / pulmonary edema	adult	0.4–1.2 mg	SL	not captured	standing	page 89

Nitrous Oxide

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	Self-administered	NEB	not captured	standing	pages 59, 61
Mild to moderate pain	peds	Self-administered	NEB	not captured	standing	pages 59, 61

Norepinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypotension / shock	adult	1–80 mcg	IV	not captured	standing	pages 70, 71, 72
Hypotension / shock	peds	0.05–2 mcg/kg	IV	not captured	standing	pages 70, 71, 72

Ondansetron

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	4 mg	IV/IM/PO	not captured	standing	page 49
Nausea / vomiting	peds	0.1 mg/kg (max 4 mg)	IV/IM/PO	not captured	standing	page 49

Oral Glucose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	15–30 g	PO	not captured	standing	pages 45, 46, 240
Hypoglycemia	adult	15–30 g	PO	not captured	standing	pages 45, 46, 240
Hypoglycemia	peds	15–30 g	PO	not captured	standing	pages 45, 46, 240
Hypoglycemia	peds	15–30 g	PO	not captured	standing	pages 45, 46, 240

Oxytocin

Indication	Population	Dose	Route	Repeat	Standing	Source
Obstetric hemorrhage	adult	10 unit	IM	not captured	standing	page 38

Pralidoxime

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	1–2 g	IV	not captured	standing	pages 50, 51
Nerve agent exposure	peds	20–50 mg/kg	IV	not captured	standing	pages 50, 51

Prednisone

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	60 mg	PO	not captured	standing	page 26

Prochlorperazine

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	5 mg	IV/IM	not captured	standing	page 49

Proparacaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2 drop	TOP	not captured	standing	pages 91, 93, 101
Other	peds	2 drop	TOP	not captured	standing	pages 91, 93, 101

Rocuronium

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI induction	adult	1 mg/kg	IV	not captured	standing	pages 186, 251

Sodium Bicarbonate

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiac arrest	adult	1–2 mEq/kg	IV	not captured	standing	pages 85, 87, 251
Cardiac arrest	peds	1 mEq/kg	IV	not captured	standing	pages 85, 87, 251
Hyperkalemia	adult	1 mEq/kg	IV/IO	not captured	standing	pages 42, 43, 251
Hyperkalemia	peds	1 mEq/kg	IV/IO	not captured	standing	pages 42, 43, 251
Other	adult	1 mEq/kg	IV/IO	not captured	standing	pages 64, 66, 251
Other	adult	1 mEq/kg	IV/IO	not captured	standing	pages 98, 99, 251
Other	peds	1 mEq/kg	IV/IO	not captured	standing	pages 64, 66, 251
Other	peds	1 mEq/kg	IV/IO	not captured	standing	pages 98, 99, 251

Succinylcholine

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI induction	adult	1.5 mg/kg	IV	not captured	standing	pages 186, 252

Tetracaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2 drop	not captured	not captured	standing	pages 101, 251
Other	peds	2 drop	not captured	not captured	standing	pages 101, 251

Tranexamic Acid

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	1 g	IV/IO	not captured	standing	page 25
Obstetric hemorrhage	adult	1 g	IV/IO	not captured	standing	pages 38, 54, 252
Trauma / hemorrhage	adult	1 g	IV/IO	not captured	standing	pages 102, 252

Cite this

New Hampshire Bureau of Emergency Medical Services, United States EMS Protocol Census. 236 dose entries, effective 2025-11-07.

https://protoquiz.com/census/agencies/new-hampshire-bureau-of-emergency-medical-services/

Outdated or wrong?

Send the current document's public URL and the listing is rebuilt from it. To have this agency removed from the census entirely, say so and it comes down the same day.